## GL: Globe Life Inc. - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.4% in mid entry zone (3.0-6.0%), top 5% cross-sectional ranking. Short-term MRS_5 (2.2%) confirms momentum alignment. Strong momentum (+4.6% 5-day acceleration). Outperforming sector by 2.5%. Caution: overbought RSI (70).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($135.98)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 2, Bearish: 5)

**1. Globe Life Inc. (NYSE:GL) Given Consensus Rating of "Moderate Buy" by Brokerages**
- Source: MarketBeat | 20251216T090817 | Bullish | Relevance: 100%
- Eleven research firms have collectively given Globe Life Inc. (NYSE:GL) a "Moderate Buy" consensus rating, with nine recommending a buy and two a hold. The average twelve-month price target is set at $164.8889. The company recently reported strong quarterly earnings, surpassing analyst estimates, and announced a quarterly dividend of $0.27 per share.

**2. Bronstein, Gewirtz & Grossman, LLC Encourages Globe Life Inc. (GL) Shareholders to Inquire about Securities Investigation**
- Source: FOX4KC.com | 20251214T160758 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. (NYSE:GL) securities who bought prior to May 8, 2019, and continue to hold them. The investigation focuses on whether the company and its officers engaged in corporate wrongdoing. The firm encourages affected shareholders to visit their website for more information and assistance.

**3. Stance Capital LLC Takes $1.98 Million Position in Globe Life Inc. $GL**
- Source: MarketBeat | 20251214T125121 | Somewhat-Bullish | Relevance: 100%
- Stance Capital LLC has bought a new position in Globe Life Inc. (NYSE:GL) worth approximately $1.98 million, acquiring 15,962 shares. Other institutional investors have also adjusted their holdings in Globe Life, which recently reported strong quarterly earnings and declared a quarterly dividend. Analysts have a "Moderate Buy" consensus rating on the stock with an average price target of $165.00.

**4. Globe Life Stock On Fire: Up 7.5% With 7-Day Winning Streak**
- Source: Trefis | 20251216T050808 | Bullish | Relevance: 100%
- Globe Life (GL) stock has seen a significant increase, rising 7.5% recently and achieving a seven-day winning streak. The article highlights this positive financial performance for the company.

**5. Morgan Stanley Adjusts PT on Globe Life to $176 From $177, Maintains Overweight Rating**
- Source: marketscreener.com | 20251215T151517 | Somewhat-Bullish | Relevance: 100%
- Morgan Stanley has adjusted its price target for Globe Life (GL) to $176, slightly down from $177, while maintaining an "Overweight" rating on the stock. This update reflects the firm's ongoing positive outlook for the life and health insurance provider. The article also notes other recent analyst adjustments and company news for Globe Life.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | TD Cowen | $199 | $182 | +9% |
| 2025-11-17 | Morgan Stanley | $177 | $179 | -1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | TD Cowen | main | Buy |
| 2025-11-17 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($5.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.7%)
- Blackrock Inc.: 7.2% (-2.1%)
- Invesco Ltd.: 4.8% (-1.9%)
- State Street Corpora: 4.1% (-3.5%)
- Wellington Managemen: 3.5% (-29.0%)

### Key Risks

1. Insider selling cluster: $5.4M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +4.6% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Forward P/E 9.4x stretched relative to 3% growth. Quality metrics strong (ROE 22%, margin 19%). Balance sheet: strong liquidity (2.8x). Insider selling cluster ($5.4M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.4B |
| Beta | 0.48 |
| 52W Range | $103.88 - $147.83 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 9.4 |
| Current P/E | 9.7 |
| YoY Growth | 2.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 0.8% to 5.4% (+4.6% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 95th percentile. MRS_5 at 2.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.10), confirming momentum. RSI overbought at 70, risk of mean reversion. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.37% (CS: 95) | Strong |
| RSI_14 | 70.5 | Overbought |
| MACD Histogram | 1.10 | Bullish |
| vs SMA20 | 1.050x | Above |
| vs SMA50 | 1.049x | Above |
| vs SMA200 | 1.083x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $140.78
- **Stop Loss:** $135.98 (3.4% risk)
- **Target:** $147.98 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 249
- **Position Value:** $35,054.22
- **Portfolio %:** 35.05%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-02-04 (Est: $3.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.54 | $4.81 | +5.9% |
| 2025Q2 | $3.25 | $3.27 | +0.8% |
| 2025Q1 | $3.24 | $3.07 | -5.2% |
| 2024Q4 | $3.12 | $3.14 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*